4//SEC Filing
Slatko Gary H 4
Accession 0001214659-19-000170
CIK 0001398733other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 11:28 AM ET
Size
5.6 KB
Accession
0001214659-19-000170
Insider Transaction Report
Form 4
Slatko Gary H
SVP, Chief Medical Officer
Transactions
- Award
Stock Option (Right to Purchase)
2019-01-02+75,000→ 75,000 totalExercise: $7.18Exp: 2029-01-02→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in three annual installments of 25%, 25% and 50% on January 2, 2020, January 2, 2021 and January 2, 2022, respectively, subject in each case to Dr. Slatko's continuous service with the Issuer from the grant date through the applicable vesting date.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001763416
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 11:28 AM ET
- Size
- 5.6 KB